Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3.5M | 724 | 95.2% |
| Unspecified | $40,707 | 4 | 1.1% |
| Honoraria | $38,316 | 17 | 1.0% |
| Travel and Lodging | $33,860 | 57 | 0.9% |
| Education | $30,129 | 3 | 0.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,210 | 9 | 0.8% |
| Food and Beverage | $6,546 | 73 | 0.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $2.2M | 545 | $0 (2024) |
| CSL Plasma Inc. | $1.3M | 228 | $0 (2024) |
| Cerus Corporation | $43,887 | 19 | $0 (2024) |
| Instrumentation Laboratory Company | $40,707 | 4 | $0 (2017) |
| Diagnostica Stago, Inc | $38,100 | 21 | $0 (2024) |
| Zimmer Biomet Holdings, Inc. | $30,000 | 1 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $12,669 | 33 | $0 (2019) |
| Haemonetics Corporation | $2,721 | 7 | $0 (2024) |
| Incyte Corporation | $1,198 | 12 | $0 (2017) |
| HemoSonics LLC | $860.22 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $834,750 | 142 | CSL Plasma Inc. ($807,450) |
| 2023 | $558,482 | 118 | CSL Plasma Inc. ($535,150) |
| 2022 | $693,289 | 133 | CSL Behring ($677,238) |
| 2021 | $756,779 | 142 | CSL Behring ($748,260) |
| 2020 | $315,870 | 109 | CSL Behring ($309,870) |
| 2019 | $296,120 | 100 | CSL Behring ($286,915) |
| 2018 | $122,723 | 56 | CSL Behring ($114,077) |
| 2017 | $129,901 | 87 | CSL Behring ($41,043) |
All Payment Transactions
887 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Haemonetics Corporation | TEG6S HEMOSTASIS SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $386.95 | General |
| Category: DEVICES | ||||||
| 12/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $6,300.00 | General |
| 12/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $3,850.00 | General |
| 12/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $3,850.00 | General |
| 12/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 12/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $9,800.00 | General |
| 12/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $6,650.00 | General |
| 12/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $4,550.00 | General |
| 12/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $4,550.00 | General |
| 12/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $4,550.00 | General |
| 12/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 12/04/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $8,400.00 | General |
| 12/04/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $3,850.00 | General |
| 11/27/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $9,800.00 | General |
| 11/27/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $6,650.00 | General |
| 11/27/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $6,300.00 | General |
| 11/20/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $11,900.00 | General |
| 11/20/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $8,050.00 | General |
| 11/20/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $6,300.00 | General |
| 11/20/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $5,950.00 | General |
| 11/20/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $4,900.00 | General |
| 11/13/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $9,800.00 | General |
| 11/13/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $9,800.00 | General |
| 11/06/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| 10/30/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $6,300.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 255 | 417 | $51,523 | $13,890 |
| 2022 | 3 | 454 | 822 | $78,597 | $26,921 |
| 2021 | 4 | 804 | 1,291 | $119,947 | $44,368 |
| 2020 | 4 | 583 | 913 | $82,097 | $32,368 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 86077 | Blood bank physician services for cross match and/or evaluation and written report | Facility | 2023 | 93 | 200 | $27,634 | $7,506 | 27.2% |
| 85390 | Coagulation function screening test with interpretation and report | Facility | 2023 | 135 | 190 | $20,298 | $5,345 | 26.3% |
| 86079 | Blood bank physician services with written report | Facility | 2023 | 27 | 27 | $3,591 | $1,039 | 28.9% |
| 85390 | Coagulation function screening test with interpretation and report | Facility | 2022 | 295 | 472 | $30,680 | $13,637 | 44.5% |
| 86077 | Blood bank physician services for cross match and/or evaluation and written report | Facility | 2022 | 97 | 287 | $39,538 | $10,921 | 27.6% |
| 86079 | Blood bank physician services with written report | Facility | 2022 | 62 | 63 | $8,379 | $2,362 | 28.2% |
| 85390 | Coagulation function screening test with interpretation and report | Facility | 2021 | 488 | 774 | $50,250 | $22,624 | 45.0% |
| 86077 | Blood bank physician services for cross match and/or evaluation and written report | Facility | 2021 | 114 | 308 | $42,196 | $12,216 | 29.0% |
| 80502 | Comprehensive, clinical pathology consultation | Facility | 2021 | 85 | 91 | $11,735 | $4,913 | 41.9% |
| 86079 | Blood bank physician services with written report | Facility | 2021 | 117 | 118 | $15,766 | $4,614 | 29.3% |
| 85390 | Coagulation function screening test with interpretation and report | Facility | 2020 | 364 | 582 | $37,830 | $17,613 | 46.6% |
| 86077 | Blood bank physician services for cross match and/or evaluation and written report | Facility | 2020 | 70 | 178 | $24,386 | $7,337 | 30.1% |
| 80502 | Comprehensive, clinical pathology consultation | Facility | 2020 | 72 | 76 | $9,640 | $4,260 | 44.2% |
| 86079 | Blood bank physician services with written report | Facility | 2020 | 77 | 77 | $10,241 | $3,159 | 30.8% |
About Dr. Majed Refaai, MD
Dr. Majed Refaai, MD is a Clinical Pathology healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1730383274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Majed Refaai, MD has received a total of $3.7M in payments from pharmaceutical and medical device companies, with $834,750 received in 2024. These payments were reported across 887 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($3.5M).
As a Medicare-enrolled provider, Refaai has provided services to 2,096 Medicare beneficiaries, totaling 3,443 services with total Medicare billing of $117,547. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Clinical Pathology
- Location Rochester, NY
- Active Since 06/11/2007
- Last Updated 07/06/2023
- Taxonomy Code 207ZC0006X
- Entity Type Individual
- NPI Number 1730383274
Products in Payments
- Kcentra (Biological) $75,842
- HemosIL (Device) $40,707
- INTERCEPT BLOOD SYSTEM FOR CRYOPRECIPITATION (Device) $38,196
- Rejuvesol Solution (Drug) $30,000
- Kovaltry (Drug) $8,619
- DEVICE-TRANSFUSION (Device) $2,903
- INTERCEPT BLOOD SYSTEM FOR PLATELETS (Device) $2,771
- TEG (Device) $2,064
- Jivi (Drug) $1,920
- Non-Covered $1,869
- TEG6S HEMOSTASIS SYSTEM (Device) $587.99
- QUNATRA QPLUS SYSTEM (Device) $463.81
- QUANTRA QPLUS SYSTEM (Device) $396.41
- No Related Product (Device) $123.73
- FERAHEME (Drug) $108.98
- Thrombate III (Biological) $99.54
- ZEPATIER (Drug) $96.55
- MONOFERRIC (Drug) $94.59
- VONVENDI (Biological) $73.44
- TEG6s HEMOSTASIS SYSTEM (Device) $69.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Pathology Doctors in Rochester
Dr. Leah Militello, Md, MD
Clinical Pathology — Payments: $2,055
Roberto Vargas, M.d, M.D
Clinical Pathology — Payments: $412.29
Dr. Nicole Pecora, Md/Phd, MD/PHD
Clinical Pathology — Payments: $92.60
Wen Lu, Md, MD
Clinical Pathology — Payments: $33.32
Dr. Scott Kirkley, M.d, M.D
Clinical Pathology
Jess Peterson, M.d, M.D
Clinical Pathology